Read WL - Search Results

1

A phase II study of irinotecan and carboplatin in advanced non-small cell lung cancer with pharmacogenomic analysis: final report.

Pillot GA, Read WL, Hennenfent KL, Marsh S, Gao F, Viswanathan A, Cummings K, McLeod HL, Govindan R. Pillot GA, et al. Among authors: read wl. J Thorac Oncol. 2006 Nov;1(9):972-8. J Thorac Oncol. 2006. PMID: 17409981 Free article. Clinical Trial.

2

Irinotecan and carboplatin in metastatic or recurrent non-small-cell lung cancer.

Govindan R, Read W, Faust J, Mc Leod H. Govindan R, et al. Oncology (Williston Park). 2003 Jul;17(7 Suppl 7):27-9. Oncology (Williston Park). 2003. PMID: 12886871 Clinical Trial.

3

Phase II study of docetaxel and irinotecan in metastatic or recurrent esophageal cancer: a preliminary report.

Govindan R, Read W, Faust J, Trinkaus K, Ma MK, Baker SD, McLeod HL, Perry MC. Govindan R, et al. Oncology (Williston Park). 2003 Sep;17(9 Suppl 8):27-31. Oncology (Williston Park). 2003. PMID: 14569845 Free article. Clinical Trial.

4

Single agent gefitinib as first line therapy in patients with advanced non-small cell lung cancer: Washington University experience.

Kommareddy A, Coplin MA, Gao F, Behnken D, Romvari E, Read W, Govindan R. Kommareddy A, et al. Lung Cancer. 2004 Aug;45(2):221-5. doi: 10.1016/j.lungcan.2004.01.022. Lung Cancer. 2004. PMID: 15246194

5

Irinotecan and carboplatin in metastatic or recurrent NSCLC: an update.

Read W, McLeod H, Govindan R. Read W, et al. Oncology (Williston Park). 2004 Dec;18(14 Suppl 14):15-7. Oncology (Williston Park). 2004. PMID: 15685828 Free article. Clinical Trial.

6

Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database.

Govindan R, Page N, Morgensztern D, Read W, Tierney R, Vlahiotis A, Spitznagel EL, Piccirillo J. Govindan R, et al. J Clin Oncol. 2006 Oct 1;24(28):4539-44. doi: 10.1200/JCO.2005.04.4859. J Clin Oncol. 2006. PMID: 17008692

7

A Phase I trial of weekly docetaxel and topotecan for solid tumors.

Lim WT, Baggstrom MQ, Read W, Fracasso PM, Govindan R. Lim WT, et al. Acta Oncol. 2008;47(2):311-5. doi: 10.1080/02841860701560340. Acta Oncol. 2008. PMID: 17896192 Clinical Trial.

8

A phase I study of docetaxel and bexarotene.

Wildi JD, Baggstrom MQ, Suresh R, Read W, Fracasso PM, Govindan R. Wildi JD, et al. Chemotherapy. 2008;54(2):125-30. doi: 10.1159/000119706. Epub 2008 Mar 7. Chemotherapy. 2008. PMID: 18332628 Clinical Trial.

9

The epidemiology of bronchioloalveolar carcinoma over the past two decades: analysis of the SEER database.

Read WL, Page NC, Tierney RM, Piccirillo JF, Govindan R. Read WL, et al. Lung Cancer. 2004 Aug;45(2):137-42. doi: 10.1016/j.lungcan.2004.01.019. Lung Cancer. 2004. PMID: 15246183

10

Differential prognostic impact of comorbidity.

Read WL, Tierney RM, Page NC, Costas I, Govindan R, Spitznagel EL, Piccirillo JF. Read WL, et al. J Clin Oncol. 2004 Aug 1;22(15):3099-103. doi: 10.1200/JCO.2004.08.040. J Clin Oncol. 2004. PMID: 15284260

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45 results

Search Page

Filters